![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Switzerland
Find below all kinds of persons from Switzerland (Schweiz / Suisse).Total search results: 1254 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Mayweg, Alexander (Alex) (Versant Ventures 202003 promoted to Managing Director joined 2016) | Partner (venture partner) | Versant Ventures | Northwestern Switzerland (region) |
| McAllister, Andres (Debiopharm 201306 CSO Resesearch + Evaluation) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Debiopharm (Group) | Région Lémanique (region) |
| McCully, James (Cellvie 202209 Co-Founder) | Company Founder | Cellvie (Group) | Zürich (region) |
| McGill, Stephen (Sequana Medical 201404– VP Sales + Marketing before Angiodynamics et al) | Sales Manager / Marketing Manager | Sequana Medical (Group) | Central Switzerland (region) |
| McGuire, Mike (Roche 200610 VP anti-infectives) | n. a. | Roche (Group) | Northwestern Switzerland (region) |
| Mégret, Dominique (Swisscom 201901 Head of Swisscom Ventures) | President/Director/Head Business Group/Unit/Division | Swisscom (Group) | Zürich (region) |
| Mehler, Michael (AXA 201208 CEO of Riemser Pharma before Actelion + Novartis) | Chief Executive Officer (CEO) | Esteve (Group) | Mecklenburg-Vorpommern (federal state) |
| Mehrling, Thomas (Purdue Pharma 201708 CEO of Mundipharma EDO GmbH) | Chief Executive Officer (CEO) | Purdue Pharma (Group) | Northwestern Switzerland (region) |
| Meier, Roger (Versameb 201812 Board Chairman) | Board member | Versameb AG | Northwestern Switzerland (region) |
| Meier, Simon (VI Partners 202206– Partner Healthcare before Roche Diagnostics Information Solution + Roche Venture Fund) | Partner (venture partner) | VI Partners AG | Central Switzerland (region) |
| Meier, Thomas (Viopas Venture Consulting 202201 Managing Partner before Santhera Pharmaceuticals) | Board member, non-executive | Viopas Venture Consulting (VVC) (Group) | Northwestern Switzerland (region) |
| Meier-Pfister, Martin (Speedel 200809) | Public Relations Manager / Investor Relations Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Meister, Robert (Selexis 201511 Head Corporate + Marketing Communications) | Public Relations Manager / Investor Relations Manager | JSR Corporation (Group) | Région Lémanique (region) |
| Mello, Virginia (Securecell 202002 Marketing Manager) | Sales Manager / Marketing Manager | Securecell (Group) | Zürich (region) |
| Menu, Philippe (Sophia Genetics 202002– CMO before McKinsey & Company) | Chief Medical Officer (CMO) | Sophia Genetics (Group) | Région Lémanique (region) |
| Mercanzini, André (Aleva Neurotherapeutics 201108 CTO) | Chief Technology/Technical Officer (CTO) | Aleva Neurotherapeutics S.A. | Région Lémanique (region) |
| Merlot, Cédric (Drugdesigntech 2007– CEO + Founder before Serono since 2001 + Sanofi-Aventis) | Chief Executive Officer (CEO) | Drugdesigntech S.A. | Région Lémanique (region) |
| Metcalfe, Ian (NovaGo Therapeutics 202009– CEO before Corlieve Therapeutics + Roche + Nestlé Health Science) | Chief Executive Officer (CEO) | NovaGo Therapeutics AG | Zürich (region) |
| Metz, Günther (Santhera 201502– appointed SVP Business Development) | Business Development Manager / Strategy Manager | Santhera (Group) | Northwestern Switzerland (region) |
| Metzger, Friedrich (Versameb 201910 CEO) | Chief Executive Officer (CEO) | Versameb AG | Northwestern Switzerland (region) |
| Metzger, Markus | n. a. | Vontobel (Group) | Zürich (region) |
| Meyer, Andreas (FGen GmbH 201704 CEO + Co-Founder) | Chief Executive Officer (CEO) | Ginkgo Bioworks (Group) | Northwestern Switzerland (region) |
| Meyer, Markus (Alentis Therapeutics 202302– COO before VP R&D Operations joined in 2019 at start of Alentis) | Chief Operating Officer (COO) | Alentis Therapeutics AG | Northwestern Switzerland (region) |
| Meyer, Thomas (Auris Medical 201306 Managing Director + Founder) | Managing Director | Altamira Therapeutics (Group) | Northwestern Switzerland (region) |
| Michel, Bruno | n. a. | IBM (Group) | Zürich (region) |
| Michel, Willy (Finox AG 201310 majority shareholder + Board President) | Board member, non-executive | Finox AG (Finox Biotech) | Espace Mittelland (region) |
| Micki, Tania (Tecan 202003– CFO before Sulzer AG + Monsanto + Gate Group + General Mills) | Chief Financial Officer (CFO) | Tecan (Group) | Zürich (region) |
| Middendorp, Oliver (Numab 201703 CBO + Co-Founder before Esbatech 2004–2010) | Chief Business Officer (CBO) | Numab (Group) | Zürich (region) |
| Miles, Nick (Cabinet Privé de Conseils 202009) | Public Relations Manager / Investor Relations Manager | Cabinet Privé de Conseils S.A. | Région Lémanique (region) |
| Miles, Nick (Speedel 200301–200802 Director Communications) | Public Relations Manager / Investor Relations Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Mills, Adrian (Novimmune 201409– CBO before GSK since 2000) | Chief Business Officer (CBO) | Novimmune S.A. | Région Lémanique (region) |
| Mills, Roger G. (Addex 201611– CMO before Acadia Pharmaceuticals + Pfizer + Gilead + Abbott + Wellcome) | Chief Medical Officer (CMO) | Addex (Group) | Région Lémanique (region) |
| Minami, Hiroko (ICN 200810– President) | n. a. | International Council of Nurses (ICN) | Région Lémanique (region) |
| Miras, Stéphane (Kelly Services 202110– promoted to Director Life Sciences CH + Swiss Leadership Team joined 2008) | President/Director/Head Business Group/Unit/Division | Kelly Services (Group) | Espace Mittelland (region) |
| Mirovsky, Pavel (PharmaSwiss 201102 CEO) | Chief Executive Officer (CEO) | Valeant (Group) | Central Switzerland (region) |
| Miserez, André (Diagene 201104 CEO) | Chief Executive Officer (CEO) | Diagene (Group) | Northwestern Switzerland (region) |
| Mitchell, Rob (Roche 200904 Global Head Virology Business) | Product Manager (personnel) | Roche (Group) | Northwestern Switzerland (region) |
| Mizrahi, Jacques (Aravis + INSERM + ElsaLys 201701 Consultant before Roche 200512 Head of Metabolic + Vascular Diseases) | Venture Partner | Aravis (Group) | Zürich (region) |
| Mohadjer, Aydin (CAMAG 201302 Corporate Marketing Manager) | Sales Manager / Marketing Manager | CAMAG (Group) | Northwestern Switzerland (region) |
| Mohan, Vikalp (Celonic 2021102 CBO 201609 VP Global Commercial Operations) | Sales Manager / Marketing Manager | Celonic (Group) | Northwestern Switzerland (region) |
| Mohr, Deana (Muvon Therapeutics 202104 CEO + Co-Founder) | Chief Medical Officer (CMO) | Muvon Therapeutics AG | Zürich (region) |
| Monin, Jean-Fabien (AC Immune 200901– CFO before 14y at bioMérieux CFO Central Europe) | Chief Financial Officer (CFO) | AC Immune S.A. (Nasdaq: ACIU) | Région Lémanique (region) |
| Monroe, Thomas Lawrence (Tom) (Actelion 201604 CEO of Vaxxilon AG) | Chief Executive Officer (CEO) | Idorsia (Group) | Northwestern Switzerland (region) |
| Montserrat, Jordi (Venturelab 202403 CEO + Co-Founder) | Chief Executive Officer (CEO) | Venturelab AG (CH) | Zürich (region) |
| Moore, Judith (AC Immune 202003 Global Head of Communications) | Public Relations Manager / Investor Relations Manager | AC Immune S.A. (Nasdaq: ACIU) | Région Lémanique (region) |
| Moore, Kevin (Tecan 201011 Director Market and Application Management for BioPharma) | Product Manager (personnel) | Tecan (Group) | Zürich (region) |
| Morgan, Victoria (Lonza 202105 Head of External Communications) | Public Relations Manager / Investor Relations Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Morris, David (Novartis 201804 Venture Partner at NVF) | Partner (venture partner) | Novartis (Group) | Northwestern Switzerland (region) |
| Morrison, Andrea (Merck (DE) 201204 Merck Serono International SA Antibodies Technologies) | n. a. | Merck (DE) (Group) | Région Lémanique (region) |
| Morscher, Elmar (Integra Biosciences 200808 CEO) | Chief Executive Officer (CEO) | Integra Holding (Group) | Eastern Switzerland (region) |
| Moser, Christian (Pevion Biotech 201201 Head of Research) | Research & Development Manager | Pevion Biotech AG | Espace Mittelland (region) |
| Moser, Markus (Prionics AG 201403 CEO) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | Zürich (region) |
| Moss, Jeremy (Roche 201207 Global Head of Point of Care at Roche Professional Diagnostics in Rotkreuz) | President/Director/Head Business Group/Unit/Division | Roche (Group) | Central Switzerland (region) |
| Mounier, Théophile (Lunaphore 202105 Corporate Finance) | Financial Manager (CFO, Financial Director, etc.) | Bio-Techne (Group) | Région Lémanique (region) |
| Mouritsen, Søren (Engimmune Therapeutics 202205 CEO + Co-Founder) | Chief Executive Officer (CEO) | Engimmune Therapeutics AG | Northwestern Switzerland (region) |
| Mous, Jan (Midatech 2010– CEO of PharMida AG before IntegraGen + Lion Bioscience + Roche) | Chief Executive Officer (CEO) | Midatech (Group) | Northwestern Switzerland (region) |
| Mueller, André J. (Addex 201106 Chairman of the Board before Actelion CFO before Biogen before Sandoz) | Board member, non-executive | Addex (Group) | Région Lémanique (region) |
| Mueller, Stefan (CureVac 201902– VP Preclinical before Sandoz Biopharmaceuticals + Merck Serono + Merck + Knoll GmbH) | Research & Development Manager | CureVac (Group) | Baden-Württemberg (federal state) |
| Muellershausen, Florian (Novartis 201902 Novartis Venture Fund) | Investment Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Muken, Ross (Sophia Genetics 202102– CFO before Click Therapeutics 201907– CFO before ISI Group + Deutsche Bank) | Chief Financial Officer (CFO) | Sophia Genetics (Group) | Région Lémanique (region) |
| Muller, André C. (Idorsia 201706– CFO before Actelion 201309– CFO before Pierre Fabre CFO) | Chief Financial Officer (CFO) | Idorsia (Group) | Northwestern Switzerland (region) |
| Muller, Arnaud (Nemis Technologies 202202 CEO + Co-Founder) | Chief Executive Officer (CEO) | Nemis Technologies AG | Zürich (region) |
| Muller, Georges (Seed Biosciences 202302 CEO + Co-Founder) | Chief Executive Officer (CEO) | Seed Biosciences S.A. | Région Lémanique (region) |
| Mundel, Trevor (Novartis 200805 Head Global Development Functions Novartis Pharma AG) | Research & Development Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Muñoz, David (Pint Pharma 201607 CEO) | Chief Executive Officer (CEO) | Pint Pharma (Group) | Switzerland_other |
| Munte, Martin (Vaccentis 202207– CEO before 12y at Amgen before AstraZeneca + Roche) | Chief Executive Officer (CEO) | Vaccentis AG | Zürich (region) |
| Murray, Campbell (Novartis 201203 Managing Director of Novartis Venture Fund) | Managing Director | Novartis (Group) | Northwestern Switzerland (region) |
| Mutel, Vincent (Addex 2002c–201106 CEO stepped down 6/11) | Chief Executive Officer (CEO) | Addex (Group) | Région Lémanique (region) |
| Mühlenbeck, Frank (aeris Capital 200912 Partner before First Ventury Equity) | Partner (venture partner) | Aeris Capital AG | Central Switzerland (region) |
| Müller, Alexandre (Dynamics Group 202104) | Public Relations Manager / Investor Relations Manager | Dynamics Group AG | Zürich (region) |
| Müller, Andreas (Climedo Health 202403– advisory board member formerly at Novartis) | Advisory Board member | Climedo Health GmbH | Bayern (federal state) |
| Müller, Michele (Micro-Sphere 201708 President + Founder) | President/Director/Head Business Group/Unit/Division | Micro-Sphere S.A. | Ticino (region) |
| Müller-Bruhn, Ronja (Stimit AG 202104 CEO + Founder) | Chief Executive Officer (CEO) | Dräger (Group) | Espace Mittelland (region) |
| Müllershausen, Florian (Novartis 201808 at Novartis Venture Fund) | n. a. | Novartis (Group) | Northwestern Switzerland (region) |
| Mürnseer, Marlies (UPM 202312 Life Sciences Sales Manager DACH at UPM Biomedicals Basel) | Sales Manager / Marketing Manager | UPM (FI) (Group) | Northwestern Switzerland (region) |
| Mäder, Christoph (Lonza 202404 Lead Independent Director + Vice Chair) | Board member, non-executive | Lonza (Group) | Northwestern Switzerland (region) |
| Märki, Iwan (Abionic 201909 CTO) | Chief Technology/Technical Officer (CTO) | Abionic S.A. | Région Lémanique (region) |
| Möhler, Hanns | n. a. | University of Zurich (UZH) | Zürich (region) |
| Möller, Thomas (BioMedPartners 201702 General Partner) | General Partner (venture partner) | BioMedPartners (Group) | Northwestern Switzerland (region) |
| Naef, Francois (Merck (DE) –201312 LEFT Merck 12/13) | General Counsel / Chief Legal Officer (CLO) | Merck (DE) (Group) | Hessen (Hesse) (federal state) |
| Nahas, Nasri G. (Spinomix 201506 CEO before GeneBio CEO) | Chief Executive Officer (CEO) | Switzerland Innovation (Group) | Région Lémanique (region) |
| Nahi, Yassin (Greater Geneva Bern area 202210 Director Life Sciences) | Business Development Manager / Strategy Manager | Greater Geneva Berne Area – Economic Development Agency (GGBa) | Région Lémanique (region) |
| Natsias, Konstantinos (CAMAG 201302 CEO) | Chief Executive Officer (CEO) | CAMAG (Group) | Northwestern Switzerland (region) |
| Nazabal, Alexis (CovalX 200902 CEO) | Chief Executive Officer (CEO) | CovalX (Group) | Zürich (region) |
| Nebel, Simon (Viopas Venture Consulting 202002 Founding Partner before Aravis 201401– Managing Partner + Founder) | Managing Partner (investment firm) | Aravis (Group) | Zürich (region) |
| Neirinck, Dirk (Endress+Hauser 201510 Managing Director of Endress+Hauser Consult AG) | Managing Director | Endress+Hauser (Group) | Northwestern Switzerland (region) |
| Nestorov, Peter (Scailyte 201901 CEO + Co-Founder) | Chief Executive Officer (CEO) | Scailyte AG | Central Switzerland (region) |
| Neukom, Beat (Kuros Biosurgery 200808c– CFO before JnJ) | Chief Financial Officer (CFO) | Kuros (Group) | Zürich (region) |
| Ney, Ursula M. (Genkyotex 201105– CEO before Antisoma COO before Charterhouse Therapeutics CEO) | Chief Executive Officer (CEO) | Calliditas Therapeutics (Group) | Région Lémanique (region) |
| Ng, Frankie (SGS –201505–202403 CEO STEPPED DOWN 3/24) | Chief Executive Officer (CEO) | SGS (Group) | Région Lémanique (region) |
| Ng, Michelle (Syngenta 202304 Head External Communications) | Public Relations Manager / Investor Relations Manager | Syngenta (Group) | Northwestern Switzerland (region) |
| Niemi, Essi (UPM 202312 Product Manager Life Sciences at UPM Biomedicals Basel) | Product Manager (personnel) | UPM (FI) (Group) | Northwestern Switzerland (region) |
| Niggemann, Björn (InSphero 201311 Head of Operations) | Chief Operating Officer (COO) | InSphero (Group) | Zürich (region) |
| Nirnberger, Thomas (BioFi 202204– CEO before Basel Area Business & Innovation) | Chief Executive Officer (CEO) | BioFi AG | Northwestern Switzerland (region) |
| Nitsch, Roger M. (Neurimmune 201809 CEO + Co-Founder + Evotec Biosystems 199906 Scientific Advisory Board) | Chief Executive Officer (CEO) | Neurimmune AG | Zürich (region) |
| Norström, Erik (Tecan 201712c– Head of Corporate Development before Chr Hansen + Nobel Biocare + Roche) | Business Development Manager / Strategy Manager | Tecan (Group) | Zürich (region) |
| Novak, Lidia (Biognosys 2019089 CFO) | Chief Financial Officer (CFO) | Bruker (Group) | Zürich (region) |
| Novak, Rodger (CRISPR Therapeutics 201712– Board Chairman 2013–201711 CEO + Co-Founder before Sanofi + Nabriva GmbH) | Board member, non-executive | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
| Novy, Karel (Biognosys 202101– promoted to COO joined 2016 before Monash Univ + ETH Zürich) | Chief Operating Officer (COO) | Bruker (Group) | Zürich (region) |
| Noyes, Catherine (GeneBio 201008 Marketing Manager) | Sales Manager / Marketing Manager | GeneBio (Group) | Région Lémanique (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
